Degenerative Mitral Valve Disease
16
2
6
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.3%
1 terminated out of 16 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (16)
Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Clinical and Fundamental Aspects of Prosthetics and Translocation of Mitral Valve Chordae
Chordal Repair for Transcatheter Mitral Valve Repair (TMVr)
Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation
Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation
Clinical Study of NovoClasp for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation
Long Term Results in Redo Mitral Valve Surgery After Mitral Valve Repair
Long Term Results of Surgical and Percutaneous Double Orefices Mitral Repair in Patient With p2 Prolapse Causing Degenerative Mitral Regurgitation
Commissural Closure to Treat Severe Mitral Regurgitation: Standing the Test of Time.
Effect of RT3D-TEE-guided Mitral Valve Repair on Outcomes in Patients With Degenerative Mitral Valve Disease
A Prospective, Multicenter Study to Evaluate the JensClip Transcatheter Valve Repair System
Safety and Effectiveness Study of Dragonfly System for Degenerative Mitral Regurgitation
EXPLORE DMR: Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation
Primary Mitral Regurgitation Repair
Mitral Annuloplasty Rings RCT